# DEep VEin Lesion OPtimisation (DEVELOP) Trial

> **NCT03640689** · NA · UNKNOWN · sponsor: **National University of Ireland, Galway, Ireland** · enrollment: 60 (estimated)

## Conditions studied

- Venous Leg Ulcer

## Interventions

- **DEVICE:** Endovenous ablation + iliac US +/- iliac stenting
- **DEVICE:** Endovenous ablation of Great Saphenous Vein

## Key facts

- **NCT ID:** NCT03640689
- **Lead sponsor:** National University of Ireland, Galway, Ireland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-15
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640689, "DEep VEin Lesion OPtimisation (DEVELOP) Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03640689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
